New pill ZT006 aims to shed pounds in obesity trial
NCT ID NCT07230132
First seen Nov 17, 2025 · Last updated May 15, 2026 · Updated 23 times
Summary
This study tests a new tablet, ZT006, for weight loss in 184 overweight or obese adults. Participants take either ZT006 or a placebo daily for 28 weeks, with the dose slowly increased to help tolerance. The main goal is to see how much weight people lose. This is a Phase 2 trial, meaning it's still early in testing for safety and effectiveness.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVERWEIGHT/OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Central Hospital Affiliated to Shandong First Medical University
Jinan, Shandong, 250000, China
-
First Hospital of Shanxi Medical University
Taiyuan, Shanxi, 030001, China
-
Handan First Hospital
Handan, Hebei, 056002, China
-
Harbin Medical University Affiliated Fourth Hospital
Harbin, Heilongjiang, 150001, China
-
Hebei Petro China Cental Hospital
Langfang, Hebei, 065000, China
-
Luoyang Third People's Hospital
Luoyang, Henan, 471002, China
-
Peking University People's Hospital
Beijing, 100044, China
-
The Second Affiliated Hospital of Nanjing Medical University
Nanjing, Jiangsu, 210003, China
-
Xi'an Daxing Hospital
Xi’an, Shanxi, 710000, China
-
YueYang People's Hospital
Yueyang, Hunan, 414022, China
Conditions
Explore the condition pages connected to this study.